Progress in the treatment of upper eyelid retraction
10.3760/cma.j.cn114453-20231114-00219
- VernacularTitle:上睑退缩的治疗进展
- Author:
Yongli LI
1
;
Menglin LU
1
;
Xiao SHEN
1
Author Information
1. 重庆医科大学附属第一医院医疗美容科，重庆 400016
- Publication Type:Journal Article
- Keywords:
Eyelids;
Upper eyelid retraction;
Müller muscle;
Levator palpebrae superioris muscle;
Thyroid eye disease
- From:
Chinese Journal of Plastic Surgery
2025;41(7):772-778
- CountryChina
- Language:Chinese
-
Abstract:
Upper eyelid retraction is clinically characterized by an abnormally elevated position of the upper eyelid margin, leading to abnormal exposure of the superior sclera. Its primary etiologies include thyroid-associated orbitopathy, neurogenic causes, iatrogenic causes, trauma, and congenital developmental anomalies. This condition significantly impacts patients’ ocular function, appearance, psychological well-being, and overall quality of life. Current treatment strategies for upper eyelid retraction are generally classified into non-surgical approaches (such as pharmacologic injections or fillers) and surgical interventions. This article reviewed the research progress in the management of upper eyelid retraction aiming to provide clinicians with a reference to assist in selecting appropriate treatment plans based on the degree of retraction in individual patients, ultimately achieving functional and aesthetic rehabilitation of the upper eyelid.
